Skip to main content
. 2009 Jul;6(7):24–29.

TABLE 1.

NONTRICYCLIC ANTIDEPRESSANTS AND THEIR RISKS OF INTERACTION WITH WARFARIN

Antidepressant Potential Inhibition Effects on Cytochrome P-450 Isoenzymes* Risk of Warfarin Interaction According to Lexi-Comp Online6 Risk of Warfarin Interaction from Clinical Psychopharmacology1
1A2 2C9/10 2C19 2D6 3A3/4
SSRIs
Sertraline -- -- -- + -- C = monitor therapy May ↑ PT(not clinically significance)
Citalopram/Escitalopram -- -- -- ++ -- C = monitor therapy May ↑ PT (not clinically significant)
Paroxetine -- -- -- +++ -- C = monitor therapy May ↑ bleeding
Fluvoxamine +++ +++ +++ -- ++ C = monitor therapy May↑ INR
Fluoxetine -- ++ ++ +++ + C = monitor therapy Avoid with warfarin
SNRIs
Venlafaxine -- -- -- -- -- No listing May ↑ INR/PT
Duloxetine -- -- -- ++ -- D = consider therapy modification --
Other
Bupropion unknown unknown unknown +++ unknown No listing May ↑ INR/PT
Mirtazapine unknown unknown unknown unknown unknown No listing --
*

All data from Preskorn et al5 except for data for mirtazapine, which is from Cozza et al4

Key:

-- =

no effect

+ =

mild effect

++ =

moderate effect

+++ =

substantial effect

Note: Gray shaded areas under specific cytochrome P-450 isoenzymes represent the major routes of warfarin metabolism

INR =

international normalized ratio

PT =

prothrombin time

SNRI =

serotontin norepinephrine reuptake inhibitor

SSRI =

selective serotonin reuptake inhibitor